| Desensitization of Renal Transplant Candidates (NCT00298883) | University of Florida | 2006-02-01 |
| A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients (NCT00720265) | Astellas Pharma Inc | 2006-02-01 |
| Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids (NCT00284947) | Novartis | 2006-01-01 |
| Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients (NCT00235781) | Washington University School of Medicine | 2006-01-01 |
| Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients. (NCT00337493) | Hoffmann-La Roche | 2005-12-01 |
| Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient (NCT00263328) | Pfizer | 2005-12-01 |
| Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation (NCT00296348) | Astellas Pharma Inc | 2005-11-01 |
| Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Simultaneous Pancreas-Kidney Transplants (NCT00267150) | Novartis Pharmaceuticals | 2005-11-01 |
| Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients (NCT00251004) | Novartis | 2005-10-01 |
| CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation (NCT00246129) | EMagnusson | 2005-10-01 |
| Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients (NCT00229138) | Novartis Pharmaceuticals | 2005-09-01 |
| Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection (NCT00133172) | Astellas Pharma Inc | 2005-07-01 |
| Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients (NCT00204334) | University Hospital Muenster | 2005-06-01 |
| CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants (NCT00788567) | Hoffmann-La Roche | 2005-06-01 |
| Rituximab for Pediatric Renal Transplant Rejection (NCT00697996) | Stanford University | 2005-06-01 |
| Trial of Folic Acid Effect on Hcy and cIMT After Kidney Tx (NCT00570856) | Shahid Beheshti University of Medical Sciences | 2005-06-01 |
| Quality of Life in Pediatric Transplant Recipients (NCT00209196) | Emory University | 2005-05-01 |
| Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients (NCT00170885) | Novartis | 2005-05-01 |
| A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients (NCT00106639) | Pfizer | 2005-05-01 |
| Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients (NCT00113269) | Astellas Pharma Inc | 2005-05-01 |
| Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics (NCT00902980) | Astellas Pharma Inc | 2005-04-01 |
| Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) (NCT00256750) | Bristol-Myers Squibb | 2005-03-01 |
| Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients (NCT00239083) | Novartis | 2005-01-01 |
| Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant (NCT00099801) | Novartis Pharmaceuticals | 2005-01-01 |
| Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients (NCT00240994) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |
| Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients (NCT00306397) | University Hospital, Basel, Switzerland | 2005-01-01 |
| Donor Recipient Kidney Function Following Open Surgical vs. Laparoscopic Kidney Donation (NCT00100516) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2004-12-23 |
| Evaluation of Kidney Function by Multi-modal Magnetic Resonance Imaging and Spectroscopy (NCT00575432) | Insel Gruppe AG, University Hospital Bern | 2004-11-01 |
| Study Evaluating Sirolimus in Kidney Transplant Recipients (NCT00195273) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-11-01 |
| Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes (NCT00598013) | Yonsei University | 2004-11-01 |
| To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation. (NCT00296361) | Astellas Pharma Inc | 2004-10-01 |
| Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation. (NCT00296309) | Astellas Pharma Inc | 2004-10-01 |
| Insulin Secretory Capacity in Insulin-independent Pancreas-Kidney Recipients Compared to Controls (NCT00618761) | University Hospital, Gasthuisberg | 2004-10-01 |
| Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy (NCT00149942) | Novartis | 2004-10-01 |
| Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients (NCT00154206) | Novartis Pharmaceuticals | 2004-09-01 |
| Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients (NCT00183248) | University of Miami | 2004-09-01 |
| A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation (NCT00189839) | Astellas Pharma Inc | 2004-08-01 |
| Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans (NCT00189202) | University of Michigan | 2004-08-01 |
| Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation (NCT00087581) | Hoffmann-La Roche | 2004-06-01 |
| Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation (NCT00297310) | Janssen-Cilag Pty Ltd | 2004-05-01 |
| The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus (NCT00166829) | National Taiwan University Hospital | 2004-05-01 |
| Study of Tolerant Kidney Transplant Recipients (NCT01338779) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-05-01 |
| Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation (NCT00098735) | Novartis Pharmaceuticals | 2004-04-01 |
| TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients (NCT00133887) | Hospices Civils de Lyon | 2004-04-01 |
| Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation (NCT00305396) | Vanderbilt University | 2004-04-01 |
| A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids (NCT00693446) | Nantes University Hospital | 2004-04-01 |
| Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant (NCT00188955) | University of Manitoba | 2004-03-01 |
| Performances of Large Language Models in Kidney Allograft Diagnostics (NCT07004660) | Paris Translational Research Center for Organ Transplantation | 2004-03-01 |
| Donor Dopamine and Initial Graft Function (NCT00115115) | Universitätsmedizin Mannheim | 2004-03-01 |
| Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation (NCT00141037) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-03-01 |
| Observational Cohort Study Renal Transplantation University Hospitals Leuven (NCT06505200) | Universitaire Ziekenhuizen KU Leuven | 2004-03-01 |
| Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation (NCT00110656) | Amgen | 2004-03-01 |
| A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients. (NCT00154245) | Novartis | 2004-01-01 |
| Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients (NCT00252655) | Wayne State University | 2004-01-01 |
| Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection (NCT00147381) | Dr. Claudia Bösmüller | 2004-01-01 |
| A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients (NCT00282230) | Astellas Pharma Inc | 2003-11-01 |
| Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults (NCT00078559) | University of Wisconsin, Madison | 2003-11-01 |
| Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant (NCT00099749) | Novartis Pharmaceuticals | 2003-11-01 |
| A Study to Evaluate FK778 in Kidney Transplant Patients (NCT00189735) | Astellas Pharma Inc | 2003-09-01 |
| Optima: Optimizing Prograf Therapy in Maintenance Allografts II (NCT00905515) | East Carolina University | 2003-08-01 |
| Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients (NCT00121810) | Hoffmann-La Roche | 2003-08-01 |
| Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients (NCT00062712) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-06-09 |
| Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant (NCT00063817) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-06-01 |
| Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients (NCT00064701) | Astellas Pharma Inc | 2003-06-01 |
| Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant (NCT00099736) | Novartis Pharmaceuticals | 2003-05-07 |
| Pre-operative Evaluation of Kidney & Pancreas Transplant Patients (NCT00580437) | University of Nebraska | 2003-05-02 |
| Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation (NCT00204191) | Uniwersytet Mikolaja Kopernika w Toruniu | 2003-05-01 |
| The Role of Reactive Oxygen Species in Ischaemia-Reperfusion Injury of the Transplanted Kidney (NCT00204178) | Uniwersytet Mikolaja Kopernika w Toruniu | 2003-04-01 |
| The Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ Transplantation (NCT00056784) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-03-20 |
| Freedom Study: Myfortic in Kidney Transplant Patients (NCT00101738) | Novartis Pharmaceuticals | 2003-03-01 |
| Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant (NCT02118896) | Astellas Pharma Europe Ltd. | 2003-02-24 |
| Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis (NCT00203281) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2003-02-01 |
| Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation (NCT00693381) | Astellas Pharma Inc | 2003-02-01 |
| Prediction of Medication Compliance Following Renal Transplantation (NCT00148187) | University of Minnesota | 2003-01-01 |
| MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients (NCT00231764) | Ekberg, Henrik, M.D. | 2002-11-01 |
| Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets (NCT00166842) | National Taiwan University Hospital | 2002-09-01 |
| A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients (NCT00282568) | Astellas Pharma Inc | 2002-08-01 |
| Minimizing Immunosuppression in Old for Old Kidney Transplantation (NCT00912678) | University of Luebeck | 2002-03-01 |
| Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients (NCT00273871) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-01-01 |
| Efficacy and Safety of Sirolimus in Combination With Tacrolimus (NCT00141804) | University Hospital Muenster | 2002-01-01 |
| Development and Validation of a Multidimensional Score to Predict Long-term Kidney Transplant Outcomes (NCT03474003) | Paris Translational Research Center for Organ Transplantation | 2002-01-01 |
| Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection (NCT00885820) | Astellas Pharma Inc | 2001-09-01 |
| Long-Term Effect of Soy Consumption on Cardio-Renal Indices and CRP in Type 2diabetes With Nephropathy (NCT00555490) | Isfahan University of Medical Sciences | 2001-04-01 |
| Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney (NCT00035555) | Bristol-Myers Squibb | 2001-03-01 |
| Calcineurin Free Immunosuppression in Renal Transplant Recipients (NCT00812123) | University Hospital, Basel, Switzerland | 2001-01-01 |
| A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients (NCT00048152) | Hoffmann-La Roche | 2000-12-01 |
| Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients (NCT00519116) | Wyeth is now a wholly owned subsidiary of Pfizer | 2000-10-01 |
| Islet Transplantation in Type 1 Diabetic Recipients of Kidney Transplants (NCT00288977) | Beth Israel Deaconess Medical Center | 2000-09-01 |
| Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal Transplantation (NCT00777933) | Samsung Medical Center | 2000-07-01 |
| Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients (NCT00098241) | Novartis Pharmaceuticals | 2000-06-01 |
| Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients (NCT00518271) | Wyeth is now a wholly owned subsidiary of Pfizer | 2000-04-01 |
| Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients (NCT00213590) | University Hospital, Rouen | 2000-04-01 |
| Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus (NCT00507793) | Wyeth is now a wholly owned subsidiary of Pfizer | 2000-04-01 |
| Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants (NCT00007787) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-04-01 |
| Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus (NCT00518375) | Wyeth is now a wholly owned subsidiary of Pfizer | 2000-04-01 |
| Estimating Glomerular Filtration Rate in Kidney Transplant Recipients (NCT05229939) | Paris Translational Research Center for Organ Transplantation | 2000-01-01 |
| Development and Validation of a Virtual Biopsy System in Kidney Transplant (NCT04759209) | Paris Translational Research Center for Organ Transplantation | 2000-01-01 |
| A Study To Test An Anti-Rejection Therapy After Kidney Transplantation (NCT00000936) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-11-01 |
| A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant (NCT00005113) | Boston Children's Hospital | 1999-07-01 |
| Live Donors for Kidney Transplants (NCT00001856) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1999-05-17 |